drugset / Trial / NCT00666328

Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage (ACCELERATE)

NCT00666328

Phase 3 Completed 37 enrolled The Medicines Company
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study was to determine the efficacy and safety of clevidipine for treating acute hypertension (high blood pressure, defined as systolic blood pressure \>160 mmHg) in patients with intracerebral hemorrhage (i.e., bleeding in the brain; stroke).

Timeline

Start
2008-06
Primary completion
2010-04
Completion
2010-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Clevidipine Small molecule 2 mg Intravenous